• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么癌症患者会死亡?

Why do patients with cancer die?

机构信息

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

University College London Hospitals NHS Foundation Trust and Central and North West London NHS Foundation Trust Palliative Care Team, London, UK.

出版信息

Nat Rev Cancer. 2024 Aug;24(8):578-589. doi: 10.1038/s41568-024-00708-4. Epub 2024 Jun 19.

DOI:10.1038/s41568-024-00708-4
PMID:38898221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7616303/
Abstract

Cancer is a major cause of global mortality, both in affluent countries and increasingly in developing nations. Many patients with cancer experience reduced life expectancy and have metastatic disease at the time of death. However, the more precise causes of mortality and patient deterioration before death remain poorly understood. This scarcity of information, particularly the lack of mechanistic insights, presents a challenge for the development of novel treatment strategies to improve the quality of, and potentially extend, life for patients with late-stage cancer. In addition, earlier deployment of existing strategies to prolong quality of life is highly desirable. In this Roadmap, we review the proximal causes of mortality in patients with cancer and discuss current knowledge about the interconnections between mechanisms that contribute to mortality, before finally proposing new and improved avenues for data collection, research and the development of treatment strategies that may improve quality of life for patients.

摘要

癌症是全球死亡的主要原因,在富裕国家和发展中国家都越来越严重。许多癌症患者的预期寿命缩短,并且在死亡时已经发生转移。然而,导致死亡和患者在死亡前恶化的更精确原因仍知之甚少。这种信息的缺乏,特别是缺乏对机制的深入了解,给开发新的治疗策略以提高晚期癌症患者的生活质量并可能延长其生命带来了挑战。此外,非常需要尽早采用现有的延长生命质量的策略。在本路线图中,我们回顾了癌症患者死亡的近端原因,并讨论了导致死亡的机制之间的相互联系的现有知识,最后提出了新的和改进的数据收集、研究和治疗策略开发途径,这可能会提高患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/7616303/5a5b8f754464/EMS197473-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/7616303/ded5e445d634/EMS197473-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/7616303/5a5b8f754464/EMS197473-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/7616303/ded5e445d634/EMS197473-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/7616303/5a5b8f754464/EMS197473-f002.jpg

相似文献

1
Why do patients with cancer die?为什么癌症患者会死亡?
Nat Rev Cancer. 2024 Aug;24(8):578-589. doi: 10.1038/s41568-024-00708-4. Epub 2024 Jun 19.
2
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
3
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
4
The global impact of noncommunicable diseases: estimates and projections.非传染性疾病的全球影响:评估与预测
World Health Stat Q. 1988;41(3-4):255-66.
5
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
6
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
7
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 5 岁以下儿童死亡率、成人死亡率、特定年龄死亡率和预期寿命,1970-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
8
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
9
Sex differentials in life expectancy and mortality in developed countries: an analysis by age groups and causes of death from recent and historical data.发达国家预期寿命和死亡率的性别差异:基于年龄组和死因的近期及历史数据分析
Popul Bull UN. 1988;25:65-107.
10
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.1990 - 2020年按病因划分的死亡率和残疾率的替代预测:全球疾病负担研究
Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.

引用本文的文献

1
The dual role of vitamin C in cancer: from antioxidant prevention to prooxidant therapeutic applications.维生素C在癌症中的双重作用:从抗氧化预防到促氧化治疗应用。
Front Med (Lausanne). 2025 Aug 29;12:1633447. doi: 10.3389/fmed.2025.1633447. eCollection 2025.
2
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer.克服乳腺癌耐药性的潜在机制与新兴策略
Cancers (Basel). 2025 Sep 8;17(17):2938. doi: 10.3390/cancers17172938.
3
Tumors hijack macrophages for iron supply to promote bone metastasis and anemia.

本文引用的文献

1
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.慢性应激通过中性粒细胞介导的微环境变化促进转移。
Cancer Cell. 2024 Mar 11;42(3):474-486.e12. doi: 10.1016/j.ccell.2024.01.013. Epub 2024 Feb 22.
2
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.帕博利珠单抗单药治疗的安全性概况,基于对 8937 例患者的汇总安全性评估。
Eur J Cancer. 2024 Mar;199:113530. doi: 10.1016/j.ejca.2024.113530. Epub 2024 Jan 11.
3
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.
肿瘤利用巨噬细胞提供铁来促进骨转移和贫血。
Cell. 2025 Aug 26. doi: 10.1016/j.cell.2025.08.013.
4
Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness.直面癌症治疗中的抗菌药物耐药性:意大利医学肿瘤学会(AIOM)调查揭示肿瘤学家的认知情况
JAC Antimicrob Resist. 2025 Aug 18;7(4):dlaf150. doi: 10.1093/jacamr/dlaf150. eCollection 2025 Aug.
5
Behavioral risk factors in oncology patients: A matched case control study from Yemen.肿瘤患者的行为危险因素:来自也门的一项配对病例对照研究。
PLoS One. 2025 Aug 7;20(8):e0329534. doi: 10.1371/journal.pone.0329534. eCollection 2025.
6
Beyond polarization: macrophage senescence in immunoregulation and cancer therapy.超越极化:巨噬细胞衰老在免疫调节和癌症治疗中的作用
Int J Biol Sci. 2025 Jun 23;21(10):4312-4333. doi: 10.7150/ijbs.115921. eCollection 2025.
7
Venous Thromboembolic Events in Cancer Immunotherapy: A Narrative Review.癌症免疫治疗中的静脉血栓栓塞事件:一项叙述性综述。
J Clin Med. 2025 Jul 11;14(14):4926. doi: 10.3390/jcm14144926.
8
Soft Extrudable Dendritic Particles with Nanostructured Tendrils for Local Adhesion and Drug Release to Bladder Cancers.具有纳米结构卷须的可软挤压树枝状颗粒用于膀胱癌的局部粘附和药物释放
Adv Mater. 2025 Jul 4:e2505231. doi: 10.1002/adma.202505231.
9
The Role of Extracellular Vesicles in the Control of Vascular Checkpoints for Cancer Metastasis.细胞外囊泡在癌症转移血管检查点控制中的作用
Cancers (Basel). 2025 Jun 12;17(12):1966. doi: 10.3390/cancers17121966.
10
Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.为他人带来希望(我们的组织助力提升研究与科学):匹兹堡大学乳腺癌快速尸检项目的研究成果
Breast Cancer Res. 2025 Jun 19;27(1):111. doi: 10.1186/s13058-025-02014-9.
接受GD2嵌合抗原受体T细胞疗法的实体瘤患者中嵌合抗原受体T细胞扩增的免疫决定因素。
Cancer Cell. 2024 Jan 8;42(1):35-51.e8. doi: 10.1016/j.ccell.2023.11.011. Epub 2023 Dec 21.
4
Glioma synapses recruit mechanisms of adaptive plasticity.神经胶质瘤突触招募适应性可塑性机制。
Nature. 2023 Nov;623(7986):366-374. doi: 10.1038/s41586-023-06678-1. Epub 2023 Nov 1.
5
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.脂肪组织和骨骼肌减少先于胰腺癌的临床诊断。
Nat Commun. 2023 Jul 18;14(1):4317. doi: 10.1038/s41467-023-40024-3.
6
Ventricular Arrhythmia in Cancer Patients: Mechanisms, Treatment Strategies and Future Avenues.癌症患者的室性心律失常:机制、治疗策略及未来方向
Arrhythm Electrophysiol Rev. 2023 May 29;12:e16. doi: 10.15420/aer.2023.04. eCollection 2023.
7
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.免疫检查点抑制剂相关心肌炎的预后:一项病例系列研究。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-004792.
8
Glioblastoma remodelling of human neural circuits decreases survival.胶质母细胞瘤重塑人类神经回路会降低存活率。
Nature. 2023 May;617(7961):599-607. doi: 10.1038/s41586-023-06036-1. Epub 2023 May 3.
9
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer.β受体阻滞剂可增强蒽环类药物对三阴性乳腺癌转移的控制作用。
Sci Transl Med. 2023 Apr 26;15(693):eadf1147. doi: 10.1126/scitranslmed.adf1147.
10
Body composition and lung cancer-associated cachexia in TRACERx.TRACERx 中的身体成分与肺癌相关性恶病质。
Nat Med. 2023 Apr;29(4):846-858. doi: 10.1038/s41591-023-02232-8. Epub 2023 Apr 12.